Bantam Pharmaceutical
New York, US · Founded 2015 · Delaware LLC
Founders & leadership
Board
VF
Victor F. KeenManager
WJ
W. James Tozer, Jr.Manager
LG
Lionel Goldfrank, IIIManager
Reported raises · per SEC filings
Form D private placements$7M disclosed across 1 round · 2015
▶$7MraisedAug 2015 · 5 investors · PharmaceuticalsRule 506(b)
▶$7MraisedAug 2015 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Victor F. KeenDirector, Promoter
- W. James Tozer, Jr.Director, Promoter
- Lionel Goldfrank, IIIDirector, Promoter
- Offering amount
- $8M
- Amount sold
- $7M
- Minimum investment
- $500K
- First sale
- Jul 2015
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Bantam Pharmaceutical raised?
- Bantam Pharmaceutical has disclosed $7M raised across 1 round.
- Where is Bantam Pharmaceutical headquartered?
- Bantam Pharmaceutical is headquartered in New York, US.